Author

K. A. Egland

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

C. L. Bausch· 2 shared E. J. Sullivan· 2 shared H. Wu· 2 shared M. D. Dunn· 1 shared S. P. J. Whelan· 1 shared T. C. Gilliland· 1 shared T. C. Luke· 1 shared T. Luke· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. L. Bausch

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Fully Human Antibody Immunoglobulin from Transchromosomic Bovines is Potent Against SARS-CoV-2 Variant Pseudoviruses

T. Luke, H. Wu, K. A. Egland, E. J. Sullivan, C. L. Bausch

This study evaluates the neutralization potency of SAB-185, a fully human antibody immunoglobulin from transchromosomic bovines, against multiple SARS-CoV-2 variants using pseudovirus assays.

bioRxiv · Aug 9, 2021 · PreprintImmunology

Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants.

Z. Liu, H. Wu, K. A. Egland, T. C. Gilliland, M. D. Dunn, T. C. Luke, E. J. Sullivan, W. B. Klimstra, C. L. Bausch, S. P. J. Whelan

This paper describes a fully human immunoglobulin from transchromosomic bovines that neutralizes SARS-CoV-2 variants, including those with mutations like E484K and N501Y.

bioRxiv · Feb 6, 2021Microbiology